Trending

Stories

Common diabetes drug may trigger rare complications for COVID-19 patients, say scientists

Tidio Live Chat Software - Add Tidio live chat software to your website in minutes. Contact visitors and turn them into happy customers. Enhance their experience and boost your sales. Get it for Free

WP Rocket - WordPress Caching Plugin

Must Read

Diabetes patients on a particular class of glucose-lowering drugs called SGLT2i may be at an increased risk for a potentially lethal condition when they contract COVID-19, warns a new study.

According to researchers from Brigham and Women’s Hospital in the US, the condition known as diabetic ketoacidosis (DKA), can arise when illness prevents cells from receiving enough glucose to fuel their functioning.

Also Read

The current study, published in the journal The American Association of Clinical Endocrinologists Clinical Case Reports, cautioned that COVID-19 patients receiving SGLT2i drugs may be at risk of a particular subset of DKA, known as euDKA.

EuDKA occurs when the body’s cells fail to absorb enough glucose and compensate by metabolizing fats instead, creating a build-up of acids called ketones, the researchers explained.

Elegant Themes - The most popular WordPress theme in the world and the ultimate WordPress Page Builder. Get a 30-day money-back guarantee. Get it for Free

They said EuDKA is characterized by lower blood sugar levels than DKA, adding that it is more difficult to diagnose.

The US FDA had earlier warned that the risk of DKA and euDKA may be increased for individuals who use SGLT2i drugs, which function by releasing excess glucose in the urine.

In the current study, the scientists studied five unusual euDKA cases brought to the diabetes inpatient services within the span of two months at the height of the pandemic in Boston.

They found that the five cases represented a markedly heightened incidence of euDKA compared to that of the previous two years, when inpatient services saw fewer than 10 euDKA cases.

According to the researchers, all five of the recent euDKA cases were observed in COVID-19 patients who were taking SGLT2i — three patients were discharged to rehabilitation facilities, one was discharged home, and one, a 52-year-old male with acute respiratory distress syndrome, died.

“We have the background knowledge of recognizing that SGLT2 inhibitors can cause DKA and euDKA,” said study co-author Naomi Fisher of the Division of Endocrinology, Diabetes, and Hypertension.

“Our report reinforces that if patients are ill or have loss of appetite or are fasting, they should pause their medication and not resume until they are well and eating properly,” Fisher said.

The researchers suspect that COVID-19 may particularly exacerbate euDKA risks.

“It’s been posited through other models that the virus may be preferentially destroying insulin-producing cells,” Fisher said.

Though the findings are observational, rather than the results of a clinical trial, the scientists encourage patients and physicians to halt SGLT2i-use in the event of illness.

“Patients should continue to monitor their blood sugar, and if the illness is prolonged or if their blood sugar is very high, they can speak to their doctor about other forms of therapy,” Fisher added.

iThemes WordPress Hosting

Stay updated

Subscribe to our newsletter and never miss an update on the latest tech, gaming, startup, how to guide, deals and more.

Latest

Stories

- Advertisement -
- Advertisement -

Latest

Grow Your Business

Place your brand in front of tech-savvy audience. Partner with us to build brand awareness, increase website traffic, generate qualified leads, and grow your business.

- Advertisement -

Grow Your Business

Get these business solutions, tools and services to help your business grow.
Elementor

Elementor -Join 5,000,000+ Professionals Who Build Better Sites With Elementor. Build your website with 100% visual design that loads faster and speeds up the process of building them.

WP Rocket

WP Rocket - Speed up your website with the most powerful caching plugin in the world. The website speed increase means better SEO ranking, user experience, and conversation. It’s a fact that Google loves a fast site.

Kinsta

Kinsta - If you are looking for WordPress managed hosting, Kinsta is in the leading front. Kinsta provides WordPress hosting for a small or large business that helps take care of all your needs regarding your website with cutting-edge technology.

OptinMonster

OptinMonster - Instantly boost leads and grow revenue with the #1 most powerful conversion optimization toolkit in the world. 700,000+ websites are using OptinMonster to turn their traffic into leads, subscribers, and sales.

Related

- Advertisement -
- Advertisement -
Tesla Records Double Net Profit in 2022 India to Produce Upcoming iPhones: Trade Minister Japanese Professor Developed A Power Semiconductor made of Diamond Google Releases New Product for India’s Merchants Indian EV Startup Unveil Two AutoBalancing Electric Scooters OPPO Find X6 Pro Images Render via Weibo Sony Develops New Tech to Reduce Noise of Image Sensors Tesla’s S & Y Models Earn Best-in-Class Cars of 2022 India Approved $320m to Promote Homegrown Payments Network Twitter Roll Out TikTok-like ‘For You’ Timeline on iOS
Nothing Phone Enters US with Beta Membership Program Finally! Apple’s VR Headset Coming this Spring Harvard Scientists Develop New Cell Therapy to Kill, and Prevent Brain Cancer HTC Vive XR Elite VR/AR Headset Now Selling for $1099 Realme 10 Launched in India with Helio G99 Gaming Chipset Twitter Data Breach Revealing User’s Private Information Instagram New Feature to Create Albums With Friend Redmi Note12 Pro Plus Launched in India